Jun 09, 2025
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.32 to $6.46.
The split itself did not change the total investment value.
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) operates in the Pharmaceuticals: major industry.
Bolt Biotherapeutics, Inc. company overviewBolt Biotherapeutics, Inc.'s most recent stock split was on June 9, 2025. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
Bolt Biotherapeutics, Inc. has split its stock once. This history records one reverse split, on June 9, 2025.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Bolt Biotherapeutics, Inc.'s 1-for-20 reverse split on June 9, 2025, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Bolt Biotherapeutics, Inc. has not announced a new split in our records. Its most recent split was on June 9, 2025, 1 year ago. Companies announce splits in advance, and any new NASDAQ:BOLT split will appear on this page.